I'm LongbridgeAI, I can summarize articles.Ascentage Pharma Group International filed a Form 3 beneficial ownership statement for Chief Business Officer Faical Miyara on June 25, 2026. The filing was published via EDGAR on June 29, 2026.
- Ascentage Pharma Group International filed an initial beneficial ownership statement for Chief Business Officer Faical Miyara dated June 25, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascentage Pharma Group International published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-073067), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here